Andrew is the Chairman of Oxford Brain Diagnostics. He is an experienced company director and investor in
early stage companies; he has worked with several successful medical technology start-ups and is currently
also the Chairman of Brainomix and a Director of Intelligent Ultrasound. He was involved in the early stages
of Internet computing in Silicon Valley and later worked to build Intel’s UK venture arm. Andrew has an MBA
from the Wharton School.
Ian is Chief Technology Officer at Oxford Brain Diagnostics. Ian is a highly accomplished software systems
designer and engineer. He co-founded Oxford-based Mode 7, a renowned and disruptive company in
the online gaming space. He has also designed and developed software for high profile clients
such as the BBC and Sky. Ian has a long history of using cutting-edge technology to create
innovative solutions in a wide range of areas.
Chief Technology Officer
Daniel’s specialty is high tech commercialization strategy and implementation. Daniel is currently Managing
Director for MedX in Europe, where he is responsible for setting up strategic partnerships for the
commercialization of a unique skin imaging technology with a software as a service and telemedicine
approach. He is working with innovation leaders in key European markets such as France, Germany, Holland and
Dr Daniel A. Kaute
Business Development Advisor
Mario is a Senior Scientist at Oxford Brain Diagnostics. After a number years working as postdoctoral
researcher at the University of Oxford he now provides analytical and scientific insights into the delivery
of the CDM® service. His research focuses mainly on combining clinical, neuropsychological and MRI data. In
2014 He obtained a Ph.D. degree in Neuropsychology from the Catholic University of the Sacred Heart of Rome.
Dr Mario Torso
Steven is the CEO & Co-founder of Oxford Brain Diagnostics. Previously he was Associate Professor in
Neuroscience at the University of Oxford with 20 years experience researching the microscopic basis of brain
disease, particularly Alzheimer’s disease. He is a world authority on the cortical disarray in dementia that
is measured by the CDM® technology.
Dr Steven Chance
CEO & Co-Founder
Jamie is a Junior Software Engineer and Data Scientist at Oxford Brain Diagnostics. After studying Medical
Engineering at Cardiff University and specialising in Neuro-Technology with an MSc at Imperial College
London he has gained experience working within the healthcare technology space before joining the team.
Junior Software Engineer/Data Scientist
Terry is the Chief Operating Officer at Oxford Brain Diagnostics. He has worked with several Oxford
University spin-out companies, with experience in business development and project management roles. He has
provided hands-on consulting support to entrepreneurs bringing medical devices to market and delivered on
strategic projects for the National Institute for Health Research (NIHR). He has extensive experience
working with patent agents to protect early-stage intellectual property. He originally studied physics and
has an MBA.
Mark is a Professor of Neuroimaging at the University of Oxford and is one of the architects of the world’s
leading MRI analysis software suite. He is one of the highest cited MRI authors globally and is editor of a
new series of books on MR imaging. Mark is a co-founder of Oxford Brain Diagnostics.
Prof. Mark Jenkinson
Michele is a Junior Software Engineer and Data Scientist at Oxford Brain Diagnostics. He graduated with an
MPhys in Physics from Durham University where he has also interned as a Computer Vision Software Engineer.
Before joining Oxford Brain Diagnostics he developed predictive algorithms for commercial clients at the
Boston Consulting Group in Milan.
Junior Software Engineer/Data Scientist
Dimitra is an Image Analyst at Oxford Brain Diagnostics. She is a graduate in Applied Neuropsychology from
the University of Bristol, UK and possesses a BSc(Hons) in Biology from University of Crete. Before joining
the team, she worked as a research assistant at University of Gothenburg where she focused on multimodal
image analysis of dementia.
Ged is the Chief Scientific Officer at Oxford Brain Diagnostics. Before this, he was the Head of Imaging
Science at Perspectum (an Oxford spin-out focused on MRI of liver disease). Ged obtained an MEng from
Cambridge and a PhD from UCL, then worked as a research fellow at UCL and Oxford.
Chief Scientific Officer
Omar is Chief Commercial officer at Oxford Brain Diagnostics. He has supported and serviced the healthcare
sector for 22 years working for IQIVIA and Ipsos Healthcare. With an international background in
sales, marketing, operations, and general management, he brings a deep understanding of the healthcare
sector. He holds an MBA from CASS Business School, London.
Chief Commercial Officer